Guillaume Cayla
Latest contributions
Managing ischaemic and bleeding risk of NSTEMI patients
22 May 2025 – From EuroPCR 2025
Gain valuable insights into managing ischemic and bleeding risks in NSTEMI patients. This session reviews optimal timing for invasive strategies, variability in care processes, radial access approaches, and innovative antithrombotic strategies such as aspirin omission and prasugrel monotherapy to minimize bleeding while optimizing outcomes.
Novel tools and techniques to manage complex PCI scenarios
22 May 2025 – From EuroPCR 2025
This session introduces novel tools and techniques to manage complex PCI scenarios. Key topics include intravascular lithotripsy advancements for in-stent restenosis, innovative balloon-assisted fenestration of covered stents, long-term outcomes of drug-eluting balloons post directional coronary atherectomy, and safety and efficacy data on a novel high-pressure cutting...
What an interventional cardiologist should know about anti-thrombotics
22 May 2025 – From EuroPCR 2025
This session provides comprehensive knowledge on anti-thrombotic management for interventional cardiologists, emphasizing effective inhibition during acute STEMI, latest evidence implementation for high bleeding risk patients, and customization of dual antiplatelet therapy in patients with high thrombotic and low bleeding risks through clinical cases and evidence-based recommendations.
Unconventional situations and complications during cardiovascular interventions
21 May 2025 – From EuroPCR 2025
Explore this session to gain expert tips and practical strategies for managing unexpected complications during cardiovascular interventions. Learn how to anticipate and avoid complications in conventional procedures and discover different approaches to tackle challenging situations in the cathlab through detailed case discussions involving PCI, TAVI, and...
STEMI and adjunctive theraphy
18 May 2023 – From EuroPCR 2023
Delve into the world of STEMI and adjunctive therapy in this session: explore the potential impact of antiplatelet therapy on achieving an "optimal" angiographic result, gain insights into the considerations surrounding tirofiban and ticagrelor use during pregnancy and delivery, discover the role of cangrelor in the...
STEMI and surgery: how to treat
18 May 2023 – From EuroPCR 2023
Discover the intricacies of managing STEMI cases in conjunction with surgical interventions with this selection of cases: explore the optimal approach for treating an inferior STEMI with culprit saphenous vein graft occlusion, investigate the blockage location in the scenario of an inferior STEMI with acute vein...
Managing high-bleeding risk in case examples
18 May 2023 – From EuroPCR 2023
In these slides, discover techniques to assess bleeding and thrombotic risk in PCI patients, explore antithrombotic options, and implement strategies for risk minimisation.
Cutting-edge technologies: clinical updates on TES, BRS, TAVR and LAA closure
17 May 2023 – From EuroPCR 2023
Watch this session to find out more about the three-year outcomes of the FUTURE-II Trial, the TARGET clinical trial roadmap, the TARGET IV NA Trial update, the twelve-month outcomes of the SAVE PROTECT Trial, and the quantitative aortographic assessment of regurgitation in patients treated with VitaFlow.
Antithrombotics in practice after PCI: from evidence to individual patient management
17 May 2022 – From EuroPCR 2022
In this session, compare the case of a typical ACS PCI patient with two cases with chronic settings to see whether there are other options to be considered as far as antithrombotic strategy is concerned.
NSTEMI PCI: LIVE case from St Thomas' Hospital - London, United Kingdom
17 May 2022 – From EuroPCR 2022
Watch the case of a 65-year-old ex-smoker, male patient, with hypertension and cholesterol, who presented with chest pain at rest, symptomatic with nausea and dizziness, and find out how this NSTE-ACE patient was treated.
Revascularisation for chronic coronary syndrome and multivessel disease (Part 1) - Session with LIVE demonstration
18 May 2021 – From EuroPCR 2021
Watch this session if you want to understand when patients with CCS and MVD should undergo revascularisation, to appraise how to select the optimal revascularisation strategy in such patients and to learn how to perform state-of-the-art PCI to achieve optimal procedural outcomes.
This session was originally presented...
How to select the most appropriate DAPT strategy in each patient?
Watch this case discussion if you want to tailor DAPT strategies based on balance between ischaemic and bleeding risks in specific clinical situations and to review the different options regarding drug choices, doses, and duration of treatment.
This session was originally presented during PCR e-Course 2020.
Trials and registries - Managing bleeding risk in search of optimal drug-device synergy
23 May 2019 – From EuroPCR 2019
Consult this session to discover the results of the latest trials and registries for the management of bleeding risk in search of optimal drug-device synergy: ROBOT-ACS, GLOBAL LEADERS, SAFE-A, and more!
New approaches in the functional assessment of coronary stenosis
22 May 2019 – From EuroPCR 2019
Consult this session to learn all about the new approaches in the functional assessment of coronary stenosis, such as the Quantitative Flow Ratio, the FAST EXTEND study, and more!
How to manage PCI in patients treated with oral anticoagulant?
22 May 2019 – From EuroPCR 2019
Consult this session to learn how to decide between different combinations of antithrombotic agents after PCI and how to manage high ischaemic risk patients treated with oral anticoagulant.
Complications of PCI
21 May 2019 – From EuroPCR 2019
Consult this session to learn all about how to efficiently manage various complications of PCI, such as intracoronary thrombus, coronary air embolism, stuck stent, and more!
